TRDA vs. SGOV
TRDA (Entrada Therapeutics, Inc.) is a stock, while SGOV (iShares 0-3 Month Treasury Bond ETF) is Ultrashort Bond fund tracking the ICE 0-3 Month US Treasury Securities Index. Over the past 3 years, TRDA returned -18.62%/yr vs 4.72%/yr for SGOV. At a correlation of -0.00, they often move in opposite directions.
Performance
TRDA vs. SGOV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TRDA achieves a -35.99% return, which is significantly lower than SGOV's 1.51% return.
TRDA
- 1D
- -0.90%
- 1M
- -58.33%
- YTD
- -35.99%
- 6M
- -34.66%
- 1Y
- -20.15%
- 3Y*
- -18.62%
- 5Y*
- —
- 10Y*
- —
SGOV
- 1D
- 0.01%
- 1M
- 0.29%
- YTD
- 1.51%
- 6M
- 1.80%
- 1Y
- 3.95%
- 3Y*
- 4.72%
- 5Y*
- 3.54%
- 10Y*
- —
TRDA vs. SGOV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
TRDA Entrada Therapeutics, Inc. | -35.99% | -40.54% | 14.58% | 11.61% | -21.03% | -28.52% |
SGOV iShares 0-3 Month Treasury Bond ETF | 1.51% | 4.24% | 5.27% | 5.12% | 1.58% | 0.02% |
Correlation
The correlation between TRDA and SGOV is -0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.04 |
Correlation (All Time) Calculated using the full available price history since Nov 1, 2021 | -0.00 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TRDA vs. SGOV — Risk / Return Rank
TRDA
SGOV
TRDA vs. SGOV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Entrada Therapeutics, Inc. (TRDA) and iShares 0-3 Month Treasury Bond ETF (SGOV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| TRDA | SGOV | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.24 | 20.28 | -20.52 |
Sortino ratioReturn per unit of downside risk | 0.35 | 275.69 | -275.34 |
Omega ratioGain probability vs. loss probability | 1.06 | 195.55 | -194.49 |
Calmar ratioReturn relative to maximum drawdown | -0.31 | 398.20 | -398.51 |
Martin ratioReturn relative to average drawdown | -0.83 | 4,462.00 | -4,462.83 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| TRDA | SGOV | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.24 | 20.28 | -20.52 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 14.73 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.27 | 12.48 | -12.76 |
Drawdowns
TRDA vs. SGOV - Drawdown Comparison
The maximum TRDA drawdown since its inception was -85.66%, which is greater than SGOV's maximum drawdown of -0.03%. Use the drawdown chart below to compare losses from any high point for TRDA and SGOV.
Loading charts...
Drawdown Indicators
| TRDA | SGOV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -85.66% | -0.03% | -85.63% |
Max Drawdown (1Y)Largest decline over 1 year | -64.75% | -0.01% | -64.74% |
Max Drawdown (3Y)Largest decline over 3 years | -76.75% | -0.01% | -76.74% |
Max Drawdown (5Y)Largest decline over 5 years | — | -0.03% | — |
Current DrawdownCurrent decline from peak | -81.20% | 0.00% | -81.20% |
Average DrawdownAverage peak-to-trough decline | -62.68% | -0.00% | -62.68% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 24.30% | 0.00% | +24.30% |
Volatility
TRDA vs. SGOV - Volatility Comparison
Entrada Therapeutics, Inc. (TRDA) has a higher volatility of 86.86% compared to iShares 0-3 Month Treasury Bond ETF (SGOV) at 0.05%. This indicates that TRDA's price experiences larger fluctuations and is considered to be riskier than SGOV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TRDA | SGOV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 86.86% | 0.05% | +86.81% |
Volatility (6M)Calculated over the trailing 6-month period | 94.74% | 0.13% | +94.61% |
Volatility (1Y)Calculated over the trailing 1-year period | 84.60% | 0.20% | +84.40% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 89.98% | 0.24% | +89.74% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 89.98% | 0.24% | +89.74% |
Dividends
TRDA vs. SGOV - Dividend Comparison
TRDA has not paid dividends to shareholders, while SGOV's dividend yield for the trailing twelve months is around 3.86%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
SGOV iShares 0-3 Month Treasury Bond ETF | 3.86% | 4.10% | 5.10% | 4.87% | 1.45% | 0.03% | 0.05% |
TRDA Entrada Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
TRDA and SGOV have a correlation of -0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TRDA has higher volatility (86.86%) compared to SGOV (0.05%). In terms of maximum drawdown, TRDA dropped -85.66% vs SGOV's -0.03%.
SGOV currently has the higher Sharpe Ratio (20.28 vs -0.24), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TRDA and SGOV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer